A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

ClinicalTrials.gov ID: NCT06835569

Public ClinicalTrials.gov record NCT06835569. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 10, 2026, 8:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/1b Multiple Cohort Trial of ALTA3263 in Patients With Advanced Solid Tumors With KRAS Mutations

Study identification

NCT ID: NCT06835569
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Alterome Therapeutics, Inc.; Industry
Enrollment: 188 participants

Conditions and interventions

Conditions

Interventions

ALTA3263 Drug
cetuximab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 4, 2025
Primary completion: Apr 30, 2029
Completion: Jul 31, 2029
Last update posted: May 5, 2026

2025 – 2029

United States locations

U.S. sites: 12
U.S. states: 8
U.S. cities: 9

Facility	City	State	ZIP	Site status
Research Site	Orlando	Florida	32827	Recruiting
Research Site	Boston	Massachusetts	02114	Recruiting
Research Site	Boston	Massachusetts	02115	Recruiting
Research Site	St Louis	Missouri	63110	Recruiting
Research Site	New York	New York	10016	Recruiting
Research Site	New York	New York	10032	Recruiting
Research Site	Durham	North Carolina	27710	Recruiting
Research Site	Nashville	Tennessee	37203	Recruiting
Research Site	Houston	Texas	77030	Recruiting
Research Site #2	San Antonio	Texas	78229	Recruiting
Research Site	San Antonio	Texas	78229	Recruiting
Research Site	Fairfax	Virginia	22031	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06835569, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 5, 2026 · Synced May 10, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06835569 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →